Tau Acetylation in the Pathogenesis of Alzheimers Disease and Other Related Tauopathies
AssigneeThe Trustees of the University of Pennsylvania
InventorsVirginia M.Y. Lee, Todd J. Cohen, John Q. Trojanowski
Life of this patent
Estimating the term…
Abstract
The present invention relates to biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders. The invention also provides compositions for detecting the biomarker as well as compositions and methods useful for treating Alzheimer's disease and other neurodegenerative disorders.
Claims20
A method of diagnosing a neurodegenerative disorder in a subject, the method comprising determining the level of at least one biomarker in a biological sample obtained from the subject, wherein an elevated level of the biomarker in the sample compared to the level of the biomarker in a control sample is an indication of a neurodegenerative disorder, and further wherein the at least one biomarker comprises acetylated tau.
A method of diagnosing a neurodegenerative disorder in a subject, the method comprising determining the level of at least one biomarker in a biological sample obtained from the subject, wherein the biomarker differentially discriminates between neurodegenerative disorders, and wherein the biomarker is acetylated tau.
A composition that specifically recognizes a biomarker associated with a neurodegenerative disorder, wherein the biomarker is acetylated tau.
A composition for treating a neurodegenerative disorder in a subject, wherein the composition reduces the level of tau acetylation).
A method of treating a neurodegenerative disorder in a subject, said method comprising administering to the subject an effective amount of a composition, wherein the composition reduces the level of tau acetylation.
Dependencies are inferred from the claim text.